Omega Therapeutics, Inc. (OMGAQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0650
-0.0200 (-23.53%)
Jul 11, 2025, 4:00 PM EDT
Omega Therapeutics Revenue
Omega Therapeutics had revenue of $2.61M in the quarter ending September 30, 2024, with 214.32% growth. This brings the company's revenue in the last twelve months to $8.10M, up 185.04% year-over-year. In the year 2023, Omega Therapeutics had annual revenue of $3.09M with 49.25% growth.
Revenue (ttm)
8.10M
Revenue Growth
+185.04%
P/S Ratio
0.45
Revenue / Employee
86.12K
Employees
94
Market Cap
3.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.09M | 1.02M | 49.25% |
Dec 31, 2022 | 2.07M | 1.93M | 1,339.58% |
Dec 31, 2021 | 144.00K | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |